To investigate whether Smad2/3, the crucial downstream effector of TGF-β signaling, could involve in YAP transcriptional regulation, we treated DLBCL cells with ITD-1, which blocked pSmad2/3 induced by TGFβ2. The gene discussed is TGFB2; the disease is diffuse large B-cell lymphoma.